Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCHE | P06276 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | AR | P10275 | 9/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | GPR119 | Q8TDV5 | 3/20 | 0.36 |
| ▸ | NOTUM | Q6P988 | 2/20 | 0.36 |
| ▸ | F2 | P00734 | 1/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.36 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27438475 | 0.83 | HDAC1 (0.47) | ARGPR119NOTUM | |
| SCHEMBL30955287 | 0.79 | BCHE (0.46) | BCHEARNOTUM | |
| SCHEMBL5797625 | 0.73 | RAB9A (0.63) | BCHEKMT2AMEN1ALDH1A1NOTUM | |
| SCHEMBL30955263 | 0.70 | SMN1; SMN2 (0.35) | BCHEKMT2AGPR119NOTUM | |
| SCHEMBL8014966 | 0.70 | BCHE (0.49) | BCHEKMT2AMEN1ALDH1A1NOTUM | |
| SCHEMBL5565636 | 0.69 | NOTUM (0.68) | ALDH1A1NOTUM | |
| SCHEMBL27442560 | 0.66 | NOTUM (0.53) | ARALDH1A1NOTUM | |
| SCHEMBL8434185 | 0.65 | CNR2 (0.48) | BCHEALDH1A1GPR119NOTUM | |
| SCHEMBL30379140 | 0.65 | BCHE (0.49) | BCHEKMT2AMEN1ALDH1A1 | |
| SCHEMBL9226464 | 0.65 | BCHE (0.49) | BCHEKMT2AMEN1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4638441-A1 | GLYCINE DERIVATIVES WITH P2X4 RECEPTOR-BLOCKING ACTIVITY AS DIAGNOSTICS AND FOR THE TREATMENT OF PAIN, INFLAMMATION, CANCER, AND OTHER P2X4 RECEPTOR-RELATED DISEASES | Rheinische Friedrich-Wilhelms-Universität Bonn (DE) | 2025-10-29 | — | — | EP | disclosed |
| WO-2024133499-A1 | GLYCINE DERIVATIVES WITH P2X4 RECEPTOR-BLOCKING ACTIVITY AS DIAGNOSTICS AND FOR THE TREATMENT OF PAIN, INFLAMMATION, CANCER, AND OTHER P2X4 RECEPTOR-RELATED DISEASES | RHEINISCHE-FRIEDRICH-WILHELMS-UNIVERSITÄT BONN (DE) | 2024-06-27 | — | — | WO | disclosed |